Ceforanide C-type crystal composition for injection and preparation method thereof
The invention discloses a crystal preparation method for high-purity ceforanide hydrochloride A-type crystal, namely (6R,7R)-3-[[[1-(carboxymethyl-1H-tetrazole-5-group] sulfur] methyl butyl-7-[[[2-(aminomethyl)-phenyl]2 acyl] amino]8-oxo-5-thia-1-azabicyclo[4,2,0] octyl-2-vinyl-formic acid hydrochlo...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses a crystal preparation method for high-purity ceforanide hydrochloride A-type crystal, namely (6R,7R)-3-[[[1-(carboxymethyl-1H-tetrazole-5-group] sulfur] methyl butyl-7-[[[2-(aminomethyl)-phenyl]2 acyl] amino]8-oxo-5-thia-1-azabicyclo[4,2,0] octyl-2-vinyl-formic acid hydrochloride and L-lysine B-type crystal respectively, crystal morphology parameters of the ceforanide hydrochloride A-type crystal and the L-lysine B-type crystal, and morphology parameters and medicinal application of ceforanide hydrochloride C-type crystal of sterile mixed powder consisting of the ceforanide hydrochloride A-type crystal and the L-lysine B-type crystal for injection for the first time. |
---|